Prestige Wealth Management Group LLC Astrazeneca PLC Transaction History
Prestige Wealth Management Group LLC
- $456 Million
- Q4 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 176 shares of AZN stock, worth $13,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176
Previous 197
10.66%
Holding current value
$13,062
Previous $15,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...